The role of small molecule Flt3 receptor protein-tyrosine kinase inhibitors in the treatment of Flt3-positive acute myelogenous leukemias
Robert Roskoski
Topics & Concepts
MidostaurinCytarabineCancer researchMedicineChronic myelogenous leukemiaMyeloidLeukemiaDaunorubicinTyrosine kinaseDecitabineMyeloproliferative neoplasmMyeloid leukemiaInternal medicineBone marrowBiologyMyelofibrosisReceptorDNA methylationGeneBiochemistryGene expressionAcute Myeloid Leukemia ResearchChronic Myeloid Leukemia TreatmentsProtein Degradation and Inhibitors